<DOC>
	<DOCNO>NCT01927406</DOCNO>
	<brief_summary>The purpose study evaluate potential secondary beneficial effect prostaglandin analogue ( PA ) treatment thyroid eye disease ( TED ) patient . This study aim determine PA would change course orbitopathy TED patient alter progression common feature TED , include fatty hypertrophy , proptosis , eyelid retraction optic nerve compression . The eye thyroid eye disease elevate intraocular pressure randomise PA treatment eye serve control eye treat Timolol .</brief_summary>
	<brief_title>The Secondary Beneficial Effects Prostaglandin Analog Treatment Thyroid Eye Disease Patients .</brief_title>
	<detailed_description />
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Graves Ophthalmopathy</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>mild moderate severe thyroid eye disease one eye age &gt; 18 year informed consent intraocular pressure &gt; 21 mmHg glaucoma suspect glaucoma diagnose one eye current prostaglandin analog intraocular pressure lower therapy sight threaten thyroid eye disease child &lt; 18 year old patient compliant treatment followup patient already prostaglandin analog treatment patient undergo cosmetic periocular procedure study exclude follow patient tolerate prostaglandin analog treatment . patient bilateral thyroid eye disease elevate intraocular pressure tolerate treatment timolol alternative intraocular pressure lower medication trusopt , combigan , cosopt .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Thyroid Eye Disease</keyword>
	<keyword>Graves ' Disease</keyword>
	<keyword>Prostaglandin Analogues</keyword>
</DOC>